Status:
RECRUITING
BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")
Lead Sponsor:
Inna Chen, MD
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
19+ years
Brief Summary
No validated biomarkers to identify PC at an early stage and to predict treatment outcomes in the individual patient exist. The objective of the present study is to find diagnostic, prognostic and pre...
Detailed Description
The overall survival of patients with pancreatic cancer (PC) is dismal and has only improved slightly during the last decades primarily due to combination chemotherapy. Early detection of PC is diffic...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Histologically verified PC (ductal adenocarcinoma) or ampullary adenocarcinoma in a resected specimen; or histopathological confirmation of carcinoma in patients not undergoing surgery in the setting of clinical and radiological characteristics which, together with the pathology, are consistent with a diagnosis of PC independently of stage
Exclusion
- • None
Key Trial Info
Start Date :
July 3 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 2 2035
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT03311776
Start Date
July 3 2008
End Date
July 2 2035
Last Update
March 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herlev & Gentofte Hospital
Herlev, Denmark, 2730